BenK...."What not everyone here may realize is that Dr. Dick Zoutman, who led the study that the article refers to, is the very same person who is leading Medizone's test trials!"
That is one heck of a tid bit! Thanks for that input. This "story" is beginning to take on real proportions for me. Just like yourself and threw, I am having a very difficult time trying to get my arms around the scope of MZEI's future potential. I am all "ga ga" over another biotech stock that has real promise. The situation here dwarfs that by many logs.
That said, with a successful beta test, I believe that the company will be quickly valued at around a billion dollars market cap. If anyone is having trouble with the pps calculation just take a billion and divide it by the outstanding stock. If you are somewhere around $4, you did good in your computations.
This PPS calculation is by no means a goal or end figure. It is merely a launching point before we get sales figures. The sky is truly the limit on this bugger!...GLTA...Jim